Vitamin D3 analogs
US6331642A · kind A · utility
6Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2000 |
| Grant date | Dec 18, 2001 |
| Priority date | — |
| Expiry date | May 24, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the formula ##STR1## wherein PA1 R.sub.1 is hydrogen or an alkyl group; PA1 R.sub.2 is hydrogen or an alkyl group; or PA1 R.sub.1, R.sub.2 and C.sub.20 together are cyclopropyl; ##STR2## PA1 R.sub.3 is alkyl, hydroxy-alkyl or fluoroalkyl; and PA1 R.sub.4 is alkyl, hydroxy-alkyl or fluoroalkyl which are useful in the treatment of breast cancer, prostate cancer, myeloid leukemia benign prostate growth, baldness and osteoporosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.